| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
96.44(B) |
| Last
Volume: |
6,527,087 |
Avg
Vol: |
8,474,413 |
| 52
Week Range: |
$48.64 - $68.84 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
86,763 |
379,467 |
903,564 |
1,880,629 |
| Total Sell Value |
$5,815,387 |
$21,972,667 |
$49,681,516 |
$91,757,177 |
| Total People Sold |
6 |
8 |
11 |
13 |
| Total Sell Transactions |
9 |
20 |
37 |
72 |
| End Date |
2024-01-14 |
2023-10-13 |
2023-04-14 |
2022-04-14 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lance Jean Fitterer |
SVP & Chief Compliance Officer |
• • – |
2014-02-16 |
4 |
D |
$13.30 |
$23,741 |
D/D |
(1,785) |
89,777 |
|
- |
|
| Lance Jean Fitterer |
SVP & Chief Compliance Officer |
• • – |
2014-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,588 |
91,562 |
|
- |
|
| Brennan Daniel J. |
EVP and CFO |
• • – |
2014-02-16 |
4 |
D |
$13.30 |
$22,131 |
D/D |
(1,664) |
71,310 |
|
- |
|
| Brennan Daniel J. |
EVP and CFO |
• • – |
2014-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,487 |
72,974 |
|
- |
|
| Nanavaty Maulik |
SVP & Pres, Neuromodulation |
• • – |
2014-02-16 |
4 |
D |
$13.30 |
$12,356 |
D/D |
(929) |
81,718 |
|
- |
|
| Nanavaty Maulik |
SVP & Pres, Neuromodulation |
• • – |
2014-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,115 |
82,647 |
|
- |
|
| Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
• • – |
2014-02-16 |
4 |
D |
$13.30 |
$123,770 |
D/D |
(9,306) |
138,139 |
|
- |
|
| Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
• • – |
2014-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
28,434 |
147,445 |
|
- |
|
| Sununu John E |
Director |
• • – |
2014-02-14 |
4 |
S |
$13.17 |
$389,318 |
D/D |
(29,561) |
18,997 |
|
- |
|
| Johnson Kristina M |
Director |
• • – |
2014-02-13 |
4 |
S |
$13.01 |
$234,106 |
D/D |
(18,000) |
3,124 |
|
- |
|
| Nicholas Nicholas J Jr |
Director |
• • – |
2014-02-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
10,000 |
4,600 |
|
- |
|
| Mario Ernest |
Director |
• • – |
2014-02-06 |
4 |
S |
$12.80 |
$218,935 |
D/D |
(17,104) |
347,855 |
|
- |
|
| Roux David J |
Director |
• • – |
2014-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,573 |
4,573 |
|
- |
|
| Mario Ernest |
Director |
• • – |
2014-02-03 |
4 |
AS |
$13.19 |
$131,884 |
D/D |
(10,000) |
364,959 |
|
- |
|
| Nicholas Nicholas J Jr |
Director |
• • – |
2014-01-21 |
4 |
GD |
$0.00 |
$0 |
I/I |
7,400 |
14,600 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• • – |
2014-01-15 |
4 |
AS |
$13.19 |
$178,100 |
D/D |
(13,500) |
83,735 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• • – |
2014-01-15 |
4 |
OE |
$7.41 |
$104,040 |
D/D |
13,500 |
97,235 |
|
- |
|
| Mario Ernest |
Director |
• • – |
2014-01-06 |
4 |
AS |
$12.50 |
$125,000 |
D/D |
(10,000) |
374,959 |
|
- |
|
| Bose Supratim |
EVP & President, Asia-Pacific |
• • – |
2014-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,925 |
33,034 |
|
- |
|
| Brennan Daniel J. |
EVP and CFOOfficer |
• – – |
2014-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
68,487 |
|
- |
|
| Mario Ernest |
Director |
• • – |
2013-12-26 |
4 |
AS |
$12.06 |
$120,600 |
D/D |
(10,000) |
384,959 |
|
- |
|
| Nicholas Nicholas J Jr |
Director |
• • – |
2013-11-27 |
4 |
GD |
$0.00 |
$0 |
I/I |
15,000 |
22,000 |
|
- |
|
| Capello Jeffrey D |
EVP & Chief Financial Officer |
• • – |
2013-11-27 |
4 |
S |
$11.70 |
$1,270,583 |
D/D |
(108,595) |
447 |
|
- |
|
| Capello Jeffrey D |
EVP & Chief Financial Officer |
• • – |
2013-11-26 |
4 |
S |
$11.82 |
$1,005,698 |
D/D |
(85,106) |
109,042 |
|
- |
|
| Capello Jeffrey D |
EVP & Chief Financial Officer |
• • – |
2013-11-26 |
4 |
OE |
$6.28 |
$296,129 |
D/D |
46,701 |
194,148 |
|
- |
|
1824 Records found
|
|
Page 7 of 73 |
|
|
0.63 (0.93%) 
